Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Muhammad Omer Jamil MD"'
Autor:
Jai Kumar Khatri MD, Ihab Tahboub MD, Khurram Anwar MD, Moh’d Masoudi MD, Vincent Graffeo MD, Muhammad Omer Jamil MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 12 (2024)
Pfizer/BioNTech (BNT162b2) is a messenger RNA (mRNA) vaccine that is highly effective in preventing the most severe outcomes of COVID-19 infection. Nucleoside-modified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines induce
Externí odkaz:
https://doaj.org/article/c97c2da5eb9e4cf594fdb8e1965afa6a
Autor:
Adarsh Sidda MD, Nikolas Kristopher Naleid MD, Gurusidda Manu MD, Vincent Graffeo MD, Muhammad Omer Jamil MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 10 (2022)
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subset of Hodgkin lymphoma (HL). It has a distinct clinical and pathological presentation. Unlike classic HL, where the predominant malignant cells are Reed Sternberg cells, the malign
Externí odkaz:
https://doaj.org/article/663752d395534abeacc0ec911008e4e1
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
Nodular localized cutaneous amyloidosis is a rare form of cutaneous amyloidosis and is characterized by an extracellular deposition of insoluble amyloid fibrils which are either primarily cutaneous or a manifestation of an underlying systemic amyloid
Externí odkaz:
https://doaj.org/article/466a0f5418a24f1d9c0bfa8a79132b49